A measured blue frame for strategy that declines as well as pursues

The home page begins with a two-column title area. The eyebrow names the role and Japan, the large heading carries Takumi's own line, Capacity promised only where we can keep it, and his short proposition sits opposite. Beneath, his portrait rests on a tinted mat inside a thin bordered figure, captioned with the role. To its right, a panel headed The practice lists four numbered capabilities: allocating capacity under shortage, customer concentration, product-range pruning under NHI revisions and licensing manufacturing technology. On a phone, the title, portrait and practice list stack in that order.

The colours are a pale blue-grey ground, a slightly deeper surface for the mat and panels, deep navy for text and a steel-blue accent for numerals, reference numbers and the cross mark beside the philosophy. Headings are set in Archivo, a sturdy grotesque sans-serif; body copy, navigation and captions use Jost, a geometric sans-serif. Nothing in the scheme is warm or decorative, which matters for Takumi's readers: outside directors, nominating committees and search advisers assessing a supplier in a regulated industry. His figures therefore read as facts rather than promotion.

After the opening, three measures appear with their context: annual revenue for the year ended March 2026, about 420 products across two plants, and headcount. Takumi's philosophy follows in a tinted panel under the fixed heading Designed for consequence, where he argues that a smaller promise kept for a decade serves patients and customers better than a larger one renegotiated. The register then lists his three cases as numbered table rows, each linking to the Impact page: nine of twenty-three transfers accepted, a ten-year exclusive contract declined, and a film licence taken for manufacture only. His authored introduction and proof points follow.

The register's titles are deliberately short; the Impact page supplies what a director would ask next. Each case names who disagreed, including the president, the finance chief and an outside director, and states what was given up: about ¥2.3 billion of annual revenue in one case and an own-product margin in another. Outcomes keep their limits, including a film line with no revenue yet. The Expertise page sets out four numbered methods in Takumi's voice, explaining site-change approvals, annual NHI price revisions and why a contract manufacturer avoids marketing authorisations that would compete with its customers.

The Career page places each appointment in a bordered panel with a large number on a tinted strip at its left edge. Inside, the dates, title and employer lead into a fact list covering sector, ownership, scale, reporting line, team and financial scope, then outcomes, the reason for the move and a narrative. Takumi's six panels run from a Toyama hospital dispensary through quality assurance and supply planning at a generic manufacturer, a trading company's healthcare investments and business development, to his present appointment. On small screens the number moves above each panel.

Board Readiness opens with a grid divided by hairline rules. The left column holds Takumi's contribution, written as a supplier's view of healthcare strategy, and his exposure: presentations to his employer's board and reports to its audit and supervisory committee. The right column lists the committees he would join and his capacity: twenty days a year, no current directorships and a preference for eldercare, home-care or care-supply companies with no tie to his employer. Two judgement examples sit below, followed by his first-year plan, conflicts and independence statement.